Ushering in the era of regenerative surgery

Minerva Surg. 2024 Apr;79(2):166-182. doi: 10.23736/S2724-5691.23.10113-4. Epub 2023 Dec 13.

Abstract

Tissue loss, irrespective of etiology, often requires extensive reconstruction. In many instances, the need exceeds what current treatments and technologies modern medicine can offer. Tissue engineering has made immense strides within the past few decades due to advances in biologics, biomaterials, and manufacturing. The convergence of these three domains has created limitless potential for future surgical care. Unfortunately, there still exists a disconnect on how to best implant these 'replacement parts' and care for the patient. It is therefore vital to develop paradigms for the integration of advanced surgical and tissue engineering technologies. This paper explores the convergence between tissue engineering and reconstructive surgery. We will describe the clinical problem of tissue loss, discuss currently available solutions, address limitations, and propose processes for integrating surgery and tissue engineering, thereby ushering in the era of regenerative surgery.

MeSH terms

  • Biocompatible Materials* / therapeutic use
  • Humans
  • Tissue Engineering*
  • Tissue Scaffolds

Substances

  • Biocompatible Materials